These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10695910)

  • 1. Nerve stimulation at 0.15 Hz when compared to 0.1 Hz speeds the onset of action of cisatracurium and rocuronium.
    Eikermann M; Peters J
    Acta Anaesthesiol Scand; 2000 Feb; 44(2):170-4. PubMed ID: 10695910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
    Amin AM; Mohammad MY; Ibrahim MF
    Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming with rocuronium to accelerate the onset time of cisatracurium during intubation.
    Lin SP; Chang KY; Chen YJ; Lin SM; Chang WK; Chan KH; Ting CK
    J Chin Med Assoc; 2009 Jan; 72(1):15-9. PubMed ID: 19181592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molar potency is not predictive of the speed of onset of atracurium.
    Kopman AF; Klewicka MM; Neuman GG
    Anesth Analg; 1999 Oct; 89(4):1046-9. PubMed ID: 10512288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neuromuscular block of atracurium and rocuronium in adults.
    Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
    Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cisatricurium in the orbicularis oculi muscle. Comparisn of the neuromuscular action of cisatracurium and atracurium in the orbicularis oculi muscle and the adductor pollicis muscle].
    de Rossi L; Fritz H; Kröber L; Klein U
    Anaesthesist; 1999 Sep; 48(9):602-6. PubMed ID: 10525592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J; San Miguel G; García V; Pelegrín F
    Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics.
    Jellish WS; Brody M; Sawicki K; Slogoff S
    Anesth Analg; 2000 Nov; 91(5):1250-5. PubMed ID: 11049917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients.
    Cantineau JP; Porte F; d'Honneur G; Duvaldestin P
    Anesthesiology; 1994 Sep; 81(3):585-90. PubMed ID: 8092503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rocuronium-cisatracurium combinations.
    Donati F; Plaud B
    Anesthesiology; 1999 Aug; 91(2):587-8. PubMed ID: 10443637
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of pretreatment with cisatracurium, rocuronium, and d-tubocurarine on succinylcholine-induced fasciculations and myalgia: a comparison with placebo.
    Joshi GP; Hailey A; Cross S; Thompson-Bell G; Whitten CC
    J Clin Anesth; 1999 Dec; 11(8):641-5. PubMed ID: 10680105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cisatracurium and rocuronium on cisatracurium precurarization and the priming principle.
    Mak PH; Irwin MG
    J Clin Anesth; 2004 Mar; 16(2):83-7. PubMed ID: 15110367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.